DE:1S90 / Seres Therapeutics, Inc. - Net Long/Short Value

Seres Therapeutics, Inc.
DE ˙ DB
6,21 € ↑0,18 (2,99%)
2026-06-05
PREZZO DELLE AZIONI
DE:1S90 / Seres Therapeutics, Inc. - Net Long/Short Value
In questa pagina sono riportate le valutazioni nette long/short per ogni partecipazione istituzionale segnalata tramite i depositi 13F o NPORT. Per calcolare il valore netto long/short, aggiungiamo il valore delle azioni al valore delle opzioni call e sottraiamo il valore delle opzioni put. I fondi che segnalano posizioni corte prese in prestito riporteranno i valori azionari come negativi. Le posizioni nette lunghe avranno numeri positivi nella colonna valore netto long/short, mentre le posizioni nette corte avranno valori negativi nella stessa colonna.
Proprietario Valore azionario
($1000)
Valore call
($1000)
Valore put
($1000)
Valore netto long/short
($1000)
Allworth Financial LP
SRS Capital Advisors, Inc.
Vontobel Holding Ltd.
BlackRock, Inc.
UBS Group AG
Lion Point Capital, LP
Morgan Stanley
SBI Securities Co., Ltd.
Geode Capital Management, Llc
Fmr Llc
Two Sigma Investments, Lp
Charles Schwab Investment Management Inc
Marshall Wace, Llp
Vanguard Global Advisers, LLC
State Street Corp
Vanguard Fiduciary Trust Co
Northern Trust Corp
Tower Research Capital LLC (TRC)
Rachor Investment Advisory Services, LLC
Vanguard Group Inc
Royal Bank Of Canada
Invesco Ltd.
Susquehanna International Group, Llp
Sound Income Strategies, LLC
Wells Fargo & Company/mn
Simplex Trading, Llc
Barclays Plc
Flagship Pioneering Inc.
Citadel Advisors Llc
UMA Financial Services, Inc.
American Century Companies Inc
Bnp Paribas Arbitrage, Sa
Vanguard Capital Management Llc
Advisor Group Holdings, Inc.
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:MCRB 6,65 USD
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista